Elsa M. Li-Ning-Tapia

Elsa M. Li-Ning-Tapia

Auto-generated profile, based on publicly available information

Elsa M. Li-Ning-Tapia

Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2020 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
NPNallasivam Palanisamy
Nallasivam Palanisamy
JYJun Yang
Jun Yang
PSPeter D.A. Shepherd
Peter D.A. Shepherd
ELElsa M. Li-Ning-Tapia
Elsa M. Li-Ning-Tapia
ELEstefania Labanca
Estefania Labanca
NNNora M. Navone
Nora M. Navone
Purpose: Advances in prostate cancer lag behind other tumor types partly due to the paucity of models reflecting key milestones in prostate cancer progression. Therefore, we develop clinically relevant prostate cancer models. Experimental Design: Since 1996, we have generated clinically annotated patient-derived xenografts (PDXs; the MDA PCa PDX series) linked to specific phenotypes reflecting all aspects of clinical prostate cancer. Results: We studied two cell line–derived xenografts and the first 80 PDXs derived from 47 human prostate cancer donors. Of these, 47 PDXs derived from 22 donors are working models and can be expanded either as cell lines (MDA PCa 2a and 2b) or PDXs. The histopathologic, genomic, and molecular characteristics (androgen receptor, ERG, and PTEN loss) maintain fidelity with the human tumor and correlate with published findings. PDX growth response to mouse castration and targeted therapy illustrate their clinical utility. Comparative genomic hybridization and sequencing show significant differences in oncogenic pathways in pairs of PDXs derived from different areas of the same tumor. We also identified a recurrent focal deletion in an area that includes the speckle-type POZ protein-like (SPOPL) gene in PDXs derived from seven human donors of 28 studied (25%). SPOPL is a SPOP paralog, and SPOP mutations define a molecular subclass of prostate cancer. SPOPLdeletions are found in 7% of The Cancer Genome Atlas prostate cancers, which suggests that our cohort is a reliable platform for targeted drug development. Conclusions: The MDA PCa PDX series is a dynamic resource that captures the molecular landscape of prostate cancers progressing under novel treatments and enables optimization of prostate cancer–specific, marker-driven therapy.

31 March 2023
Verified
Other
Open access
NPNallasivam Palanisamy
Nallasivam Palanisamy
JYJun Yang
Jun Yang
PSPeter D.A. Shepherd
Peter D.A. Shepherd
ELElsa M. Li-Ning-Tapia
Elsa M. Li-Ning-Tapia
ELEstefania Labanca
Estefania Labanca
NNNora M. Navone
Nora M. Navone
Clinical information and pathologic diagnosis of one human donor for 2 cell lines and of 47 human donors for 80 PDXs

31 March 2023
Verified
Other
Open access
NPNallasivam Palanisamy
Nallasivam Palanisamy
JYJun Yang
Jun Yang
PSPeter D.A. Shepherd
Peter D.A. Shepherd
ELElsa M. Li-Ning-Tapia
Elsa M. Li-Ning-Tapia
ELEstefania Labanca
Estefania Labanca
NNNora M. Navone
Nora M. Navone
Whole-genome copy number analysis of 37 MDA PCa PDXs derived from 28 human donor PCas

31 March 2023
Verified
Other
Open access
NPNallasivam Palanisamy
Nallasivam Palanisamy
JYJun Yang
Jun Yang
PSPeter D.A. Shepherd
Peter D.A. Shepherd
ELElsa M. Li-Ning-Tapia
Elsa M. Li-Ning-Tapia
ELEstefania Labanca
Estefania Labanca
NNNora M. Navone
Nora M. Navone
PDXs growth rate and list of publications in which MDA PCa PDX were used.

31 March 2023
Verified
Other
Open access
NPNallasivam Palanisamy
Nallasivam Palanisamy
JYJun Yang
Jun Yang
PSPeter D.A. Shepherd
Peter D.A. Shepherd
ELElsa M. Li-Ning-Tapia
Elsa M. Li-Ning-Tapia
ELEstefania Labanca
Estefania Labanca
NNNora M. Navone
Nora M. Navone
AR, ERG, and PTEN status on MDA PCa PDXs

31 March 2023
Verified
Other
Open access
NPNallasivam Palanisamy
Nallasivam Palanisamy
JYJun Yang
Jun Yang
PSPeter D.A. Shepherd
Peter D.A. Shepherd
ELElsa M. Li-Ning-Tapia
Elsa M. Li-Ning-Tapia
ELEstefania Labanca
Estefania Labanca
NNNora M. Navone
Nora M. Navone
Whole-genome copy number analysis of 3 MDA PCa PDXs